InnoStudio launches simultaneous COVID-19 drug research in Space and on Earth

Published November June 12, 2020 10:48 ET on Globenewswire

BUDAPEST, HUNGARY; BRUSSELS, BELGIUM; TOKYO, JAPAN, June 12, 2020 (GLOBE NEWSWIRE) — The COVID-19 pandemic has generated new challenges in drug discovery and development, including the real need for rapid yielding of results, achieving better resolutions for relevant protein structures, and even synthesizing promising but not-yet-existing heterocyclic active molecules. InnoStudio Inc. announces the initiation of an international and pre-competitive collaboration to develop a project where the advantages of the microgravity environment will be combined with advanced drug research, development and formulation efforts.

Members of the consortium will incorporate pharmaceutical research companies including ComInnex (HU) and universities involved in drug research, companies specialized in space chemistry, as well as private and public space technology companies including Japan Manned Space Systems Corporation (JP), Space Applications Services (BE) and SpacePharma (CH/ISR).

Dr. Ferenc Darvas, Executive President of InnoStudio; Dr. Gergo Mezohegyi, Manager of the Consortium stated: “Most clinical trials for COVID-19 treatments have focused so far on testing already existing drugs, originally developed for treating other diseases or health problems. Although offering a relatively fast result, efficiency of already existing drugs for treating the coronavirus can be expected to be moderate at most. The present Consortium targets the development and validation of highly efficient active compounds against SARS-CoV-2 while conducting drug discovery simultaneously and in a synchronized manner in space and on Earth. Using the well-known advantages provided by microgravity for such applications, we are committed to realise protein crystallization, synthetic chemistry and nanotechnology advances in parallel to classical ground-based research. The outcome of the project, together with the chemical formulation methods applied in space, are expected to be a promising solution not only for understanding how to efficiently treat COVID-19 but also for supporting the rapid control of virus outbreaks of the future.”

Alexander Drijver, CEO of ComInnex stated: “It’s a great privilege to participate in this project that seeks to push the boundaries of synthetic chemistry and drug discovery. We look forward to other pharmaceutical research companies joining this effort, sharing knowledge and experience and progressing science to new limits.”

Contact:
For more information, please contact
gergo.mezohegyi@innostudio.org

About Consortium members
InnoStudio Inc., with the support of Japan Manned Space Systems Corporation and Space Applications Services / ICE Cubes Service, executed successful drug discovery related experiments on the International Space Station (ISS) in December 2019.

Upcoming Events

ISSR&D CONFERENCE, August 2021

ISSR&D CONFERENCE, August 2021

We are pleased to inform you that InnoStudio will hold a presentation, entitled „Effect of microgravity on COVID-19 drug formulation on ISS” at ISSRDC 2021, the 10th Annual International Space Station Research and Development Conference on August 16 in the Biology and...

Social Media

Follow our daily updated Social Media pages for the latest news, event,curiosities and fun.

Latest News & Events

ISSR&D CONFERENCE, August 2021

ISSR&D CONFERENCE, August 2021

We are pleased to inform you that InnoStudio will hold a presentation, entitled „Effect of microgravity on COVID-19 drug formulation on ISS” at ISSRDC 2021, the 10th Annual International Space Station Research and Development Conference on August 16 in the Biology and...

ESA In-Orbit Economy workshop July 20, 2021

ESA In-Orbit Economy workshop July 20, 2021

We are honored to be invited to ESA’s upcoming workshop “In-Orbit Economy” on July 20, 2021, from 9:45AM to 13:00PM CEST, live on WebEx. President & CEO Dr. Ferenc Darvas will join the roundtable discussion and talk about how to bridge the gap between zero gravity...

Hungarians develop more effective COVID drugs in space

Hungarians develop more effective COVID drugs in space

Published May 7, 2021 on 24.hu In the last few months, in addition to vaccine developments against the coronavirus, little has been heard of regarding what efforts have been made to develop new medicines for the treatment of already covid infected patients. Regarding...

Latest Articles

Hungarians develop more effective COVID drugs in space

Hungarians develop more effective COVID drugs in space

Published May 7, 2021 on 24.hu In the last few months, in addition to vaccine developments against the coronavirus, little has been heard of regarding what efforts have been made to develop new medicines for the treatment of already covid infected patients. Regarding...

InnoStudio cited in the lead space journal by Roscosmos

InnoStudio cited in the lead space journal by Roscosmos

The recent and successful study of InnoStudio and CycloLab for COVID-19 drug research in space has been gaining attention and receiving positive feedback worldwide. The Roscosmos State Corporation for Space Activities found our idea and experiment valuable enough to...

COVID-19 drug research and bio-mining launching to Space Station

COVID-19 drug research and bio-mining launching to Space Station

For the past 20 years, astronauts have been performing experiments on the International Space Station. Science in low Earth orbit is not only hugely important in preparation for continued space exploration, the research also benefits life on Earth. We’ve seen...